For example, although there is evidence to suggest that ANG2 is involved in the vascular regression of co-opted tumor vessels as well as subsequent regrowth, it remains unknown how ANG2-mediated vascular co-option during tumor progression contributes to anti-VEGF resistance. This evidence concerns the gene VEGFA and neoplasm.